Algorithmic Computation of Combined LT4 Plus LT3 Replacement Therapies for Primary Hypothyroid Patients Individualized by Sex, Height, and Weight

Background/Methods: Levothyroxine (LT4) monotherapy fails to fully normalize thyroid hormone levels or relieve symptoms in 10–20% of hypothyroid patients, prompting interest in combination therapy with added liothyronine (LT3). Existing dosing guidance is largely qualitative. Using the p-THYROSIM mechanistic model—previously fitted and validated against data from 655 patients—we developed computational algorithms from ∼400 simulations to generate individualized residual thyroid function (RTF) values and combination LT4/LT3 dosing recommendations based on a patient’s sex, height ( H ), weight ( W ), and measured hormone values [TSH, free thyroxine (fT4), and free triiodothyronine (fT3) or total T3 (TT3)]. We implemented these in a user-friendly clinical software package as an app called LT43DOSING. Results: Simulated temporal plots of fT4, fT3, and TSH for combined dosages in available pill sizes are computed and reported as outputs of LT43DOSING, along with RTFs, separately for both sexes, with body mass indexes (BMIs) ranging from ∼15 to 40. Computed RTFs and dosages are based on patient H , W , and serum hormone concentrations provided as input data. Our findings show that both W and H affect dosing in a nonlinear manner, especially at BMI extremes, whereas sex made little difference. Only combination therapy was able to normalize fT3 levels. Conclusions: In simulated identical BMI patients, different H and W combinations produced markedly different RTF values, leading to more accurate dosing predictions based on body size. Simulated combination therapy normalized fT3 levels whereas monotherapy did not, particularly for overtly hypothyroid patients.

Authors

Institutions

Publication Details

Journal
Thyroid
Published
2026-11-18
DOI
https://doi.org/10.1177/10507256261502926
Primary Topic
Thyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Algorithmic Computation of Combined LT4 Plus LT3 Replacement Therapies for Primary Hypothyroid Patients Individualized by Sex, Height, and Weight

Joseph J. DiStefano, Kasra Navabi, Katarina Reid, Rushil Shah
3 links
Thyroid
Thyroid Disorders and Treatments
article

Algorithmic Computation of Combined LT4 Plus LT3 Replacement Therapies for Primary Hypothyroid Patients Individualized by Sex, Height, and Weight

Joseph J. DiStefano, Kasra Navabi, Katarina Reid, Rushil Shah
article en

Abstract

Background/Methods: Levothyroxine (LT4) monotherapy fails to fully normalize thyroid hormone levels or relieve symptoms in 10–20% of hypothyroid patients, prompting interest in combination therapy with added liothyronine (LT3). Existing dosing guidance is largely qualitative. Using the p-THYROSIM mechanistic model—previously fitted and validated against data from 655 patients—we developed computational algorithms from ∼400 simulations to generate individualized residual thyroid function (RTF) values and combination LT4/LT3 dosing recommendations based on a patient’s sex, height ( H ), weight ( W ), and measured hormone values [TSH, free thyroxine (fT4), and free triiodothyronine (fT3) or total T3 (TT3)]. We implemented these in a user-friendly clinical software package as an app called LT43DOSING. Results: Simulated temporal plots of fT4, fT3, and TSH for combined dosages in available pill sizes are computed and reported as outputs of LT43DOSING, along with RTFs, separately for both sexes, with body mass indexes (BMIs) ranging from ∼15 to 40. Computed RTFs and dosages are based on patient H , W , and serum hormone concentrations provided as input data. Our findings show that both W and H affect dosing in a nonlinear manner, especially at BMI extremes, whereas sex made little difference. Only combination therapy was able to normalize fT3 levels. Conclusions: In simulated identical BMI patients, different H and W combinations produced markedly different RTF values, leading to more accurate dosing predictions based on body size. Simulated combination therapy normalized fT3 levels whereas monotherapy did not, particularly for overtly hypothyroid patients.

Thyroid
University of California, Los Angeles (US), UCLA Health (US), UCLA Medical Center (US)
Good health and well-being
Thyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon